These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 17453877)

  • 1. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
    Zvosec DL; Smith SW; Litonjua R; Westfal RE
    Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine does not effect arousal but produces toxicity in an animal model of severe gamma-hydroxybutyrate intoxication.
    Bania TC; Chu J
    Acad Emerg Med; 2005 Mar; 12(3):185-9. PubMed ID: 15741579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?
    Caldicott DG; Kuhn M
    Ann Emerg Med; 2001 Jan; 37(1):99-102. PubMed ID: 11145779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
    Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
    Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-hydroxybutyrate (GHB): a new drug of misuse.
    Williams H; Taylor R; Roberts M
    Ir Med J; 1998; 91(2):56-7. PubMed ID: 9617031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical course of gamma-hydroxybutyrate overdose.
    Chin RL; Sporer KA; Cullison B; Dyer JE; Wu TD
    Ann Emerg Med; 1998 Jun; 31(6):716-22. PubMed ID: 9624311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new drug reaches Switzerland: coma after intake of gamma-hydroxybutyrate (GHB)].
    Iten PX; Oestreich A; Lips R; Brabetz M
    Schweiz Med Wochenschr; 2000 Mar; 130(10):356-61. PubMed ID: 10763213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case series of 226 γ-hydroxybutyrate-associated deaths: lethal toxicity and trauma.
    Zvosec DL; Smith SW; Porrata T; Strobl AQ; Dyer JE
    Am J Emerg Med; 2011 Mar; 29(3):319-32. PubMed ID: 20825811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
    Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
    Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital in the field: prehospital management of GHB intoxication by medical assistance teams.
    Dutch MJ; Austin KB
    Prehosp Disaster Med; 2012 Oct; 27(5):463-7. PubMed ID: 22809488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sudden coma in a 20-year-old man].
    Herbrand R; Greminger P; Schurter G; Pletscher W; Kupferschmidt H
    Praxis (Bern 1994); 2000 Aug; 89(34):1326-30. PubMed ID: 11021186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to "Insufficient evidence that agitation is common in gamma-hydroxybutyrate (GHB) toxicity," submitted in response to our original article entitled, "Agitation is common in gamma-hydroxybutyrate toxicity," published in AJEM, May 2005.
    Zvosec DL; Smith SW
    Am J Emerg Med; 2006 May; 24(3):388-9. PubMed ID: 16635731
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gamma-hydroxybutyrate, a new central nervous system stimulant].
    Strange DG; Jensen D
    Ugeskr Laeger; 1999 Dec; 161(50):6934-6. PubMed ID: 10643381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.
    Li J; Stokes SA; Woeckener A
    Ann Emerg Med; 1998 Jun; 31(6):729-36. PubMed ID: 9624313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
    Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
    QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes in children with hyoscyamus niger intoxication not receiving physostigmine therapy.
    Doneray H; Orbak Z; Karakelleoglu C
    Eur J Emerg Med; 2007 Dec; 14(6):348-50. PubMed ID: 17968201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
    Engelsen J; Christensen HR
    Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
    Liakoni E; Walther F; Nickel CH; Liechti ME
    Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of quetiapine-induced altered mental status with physostigmine: a case series.
    Cole JB; Stellpflug SJ; Ellsworth H; Harris CR
    Am J Emerg Med; 2012 Jul; 30(6):950-3. PubMed ID: 21802878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physostigmine as a treatment for gamma-hydroxybutyrate toxicity: a review.
    Traub SJ; Nelson LS; Hoffman RS
    J Toxicol Clin Toxicol; 2002; 40(6):781-7. PubMed ID: 12475191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.